Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Rolighed

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Ugeskrift for Laeger|October 23, 2025
[Surgical treatment of hyperparathyroidism]Tina Toft Kristensen, Waldemar Trolle, Lars Rolighed, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2013
PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatmentTanja Sikjaer, Anne Kristine Amstrup, Lars Rolighed, et al.
European Journal of Endocrinology|February 4, 2015
No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trialLars Rolighed, Lars Rejnmark, Tanja Sikjaer, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trialLars Rolighed, Lars Rejnmark, Tanja Sikjaer, et al.
Clinical Endocrinology|November 4, 2010
Vitamin D status, physical performance and body mass in patients surgically cured for primary hyperparathyroidism compared with healthy controls - a cross-sectional studyAnne Kristine Amstrup, Lars Rejnmark, Peter Vestergaard, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 12, 2016
Concurrent Hypoparathyroidism Is Associated With Impaired Physical Function and Quality of Life in HypothyroidismTanja Sikjaer, Emil Moser, Lars Rolighed, et al.
Calcified Tissue International|June 5, 2014
Increased trabecular volumetric bone mass density in Familial Hypocalciuric Hypercalcemia (FHH) type 1: a cross-sectional studyNiels Frederik Breum Jakobsen, Lars Rolighed, Emil Moser, et al.
Scientific Reports|March 31, 2019
Innervation is higher above Bone Remodeling Surfaces and in Cortical Pores in Human Bone: Lessons from patients with primary hyperparathyroidismManasi Sayilekshmy, Rie Bager Hansen, Jean-Marie Delaissé, et al.
The American Journal of Pathology|February 11, 2014
Correlation between absence of bone remodeling compartment canopies, reversal phase arrest, and deficient bone formation in post-menopausal osteoporosisThomas L Andersen, Ellen M Hauge, Lars Rolighed, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2018
Prevalence and Risk of Vertebral Fractures in Primary Hyperparathyroidism: A Nested Case-Control StudyHenriette Ejlsmark-Svensson, Lise Sofie Bislev, Siv Lajlev, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Ugeskrift for Laeger|October 23, 2025
[Surgical treatment of hyperparathyroidism]Tina Toft Kristensen, Waldemar Trolle, Lars Rolighed, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2013
PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatmentTanja Sikjaer, Anne Kristine Amstrup, Lars Rolighed, et al.
European Journal of Endocrinology|February 4, 2015
No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trialLars Rolighed, Lars Rejnmark, Tanja Sikjaer, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trialLars Rolighed, Lars Rejnmark, Tanja Sikjaer, et al.
Clinical Endocrinology|November 4, 2010
Vitamin D status, physical performance and body mass in patients surgically cured for primary hyperparathyroidism compared with healthy controls - a cross-sectional studyAnne Kristine Amstrup, Lars Rejnmark, Peter Vestergaard, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 12, 2016
Concurrent Hypoparathyroidism Is Associated With Impaired Physical Function and Quality of Life in HypothyroidismTanja Sikjaer, Emil Moser, Lars Rolighed, et al.
Calcified Tissue International|June 5, 2014
Increased trabecular volumetric bone mass density in Familial Hypocalciuric Hypercalcemia (FHH) type 1: a cross-sectional studyNiels Frederik Breum Jakobsen, Lars Rolighed, Emil Moser, et al.
Scientific Reports|March 31, 2019
Innervation is higher above Bone Remodeling Surfaces and in Cortical Pores in Human Bone: Lessons from patients with primary hyperparathyroidismManasi Sayilekshmy, Rie Bager Hansen, Jean-Marie Delaissé, et al.
The American Journal of Pathology|February 11, 2014
Correlation between absence of bone remodeling compartment canopies, reversal phase arrest, and deficient bone formation in post-menopausal osteoporosisThomas L Andersen, Ellen M Hauge, Lars Rolighed, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2018
Prevalence and Risk of Vertebral Fractures in Primary Hyperparathyroidism: A Nested Case-Control StudyHenriette Ejlsmark-Svensson, Lise Sofie Bislev, Siv Lajlev, et al.
Pageof 7